TradingView
AlenCiken
Jan 28, 2019 11:15 AM
FDA lifts partial hold on Mersana cancer drug trial, but shares
NASDAQ:MRSN
1D
Mersana Therapeutics, Inc.
NASDAQ
Description
⋅
Jan 28, 2019 11:15 AM
Shares of Cambridge-based Mersana Therapeutics Inc. plunged Monday despite announcing that the FDA would allow it to fully restart a cancer drug trial that was paused in July after one patient died.
bizjournals.com/boston/news/2018/09/17/fda-lifts-partial-hold-on-mersana-cancer-drug.html
globenewswire.com/news-release/2018/09/17/1571586/0/en/Mersana-Announces-FDA-Lifts-Partial-Clinical-Hold-for-XMT-1522.html
Trend Analysis
Chart Patterns
Technical Indicators
More